> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Withdraws 8 No-Longer-Marketed ANDAs
- URL: https://www.fdaweb.com/fda-withdraws-8-no-longer-marketed-andas-2/
- Published: 2023-06-01T12:00:00.000Z
- Updated: 2026-09-14T18:35:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154586

*Federal Register* notice: FDA is withdrawing approval of eight ANDAs from multiple applicants after they informed the agency that the products were no longer marketed and requested they be withdrawn. The withdrawn products are:

- Hospira’s metoprolol tartrate injectable,
- Tolmar’s calcipotriene solution
- American Regent’s dorzolamide HCl solution/drops
- Arise Pharmaceuticals’ ibuprofen suspension
- Wisconsin Medical Radiopharmacy’s ammonia N 13 injectable
- Fresenius Kabi USA’s amikacin sulfate injectable
- Essential Isotopes’ ammonia N 13 injectable
- University of Texas Southwestern Medical Center’s fludeoxyglucose F18 injectable